Literature DB >> 23220037

Doxorubicin decreases paraquat accumulation and toxicity in Caco-2 cells.

Renata Silva1, Helena Carmo, Vânia Vilas-Boas, Paula Guedes de Pinho, Ricardo Jorge Dinis-Oliveira, Félix Carvalho, Isabel Silva, Paulo Correia-de-Sá, Maria de Lourdes Bastos, Fernando Remião.   

Abstract

P-glycoprotein (P-gp) is an efflux pump belonging to the ATP-binding cassette transporter superfamily expressed in several organs. Considering its potential protective effects, the induction of de novo synthesis of P-gp could be used therapeutically in the treatment of intoxications by its substrates. The herbicide paraquat (PQ) is a P-gp substrate responsible for thousands of fatal intoxications worldwide that still lacks an effective antidote. The aim of the present work was to evaluate the effectiveness of such an antidote by testing whether doxorubicin (DOX), a known P-gp inducer, could efficiently protect Caco-2 cells against PQ cytotoxicity, 6 h after the incubation with the herbicide, reflecting a real-life intoxication scenario. Cytotoxicity was evaluated by the MTT assay and PQ intracellular concentrations were measured by gas chromatography-ion trap-mass spectrometry (GC-IT-MS). Also, the DOX modulatory effect on choline uptake transport system was assessed by measuring the uptake of [³H]-choline. The results show that DOX exerts protective effects against PQ cytotoxicity, preventing the intracellular accumulation of the herbicide. These protective effects were not completely prevented by the incubation with the UIC2 antibody, a specific P-gp inhibitor, suggesting the involvement of alternative protection mechanisms. In fact, DOX also efficiently inhibited the choline transport system that influences PQ cellular uptake. In conclusion, in this cellular model, DOX effectively protects against PQ toxicity by inducing P-gp and through the interaction with the choline transporter, suggesting that compounds presenting this double feature of promoting the efflux and limiting the uptake of PQ could be used as effective antidotes to treat intoxications.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23220037     DOI: 10.1016/j.toxlet.2012.11.028

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  5 in total

1.  Absence of P-glycoprotein transport in the pharmacokinetics and toxicity of the herbicide paraquat.

Authors:  Sarah E Lacher; Julia N Gremaud; Kasse Skagen; Emily Steed; Rachel Dalton; Kent D Sugden; Fernando Cardozo-Pelaez; Catherine M T Sherwin; Erica L Woodahl
Journal:  J Pharmacol Exp Ther       Date:  2013-12-02       Impact factor: 4.030

2.  Development of novel rifampicin-derived P-glycoprotein activators/inducers. synthesis, in silico analysis and application in the RBE4 cell model, using paraquat as substrate.

Authors:  Vânia Vilas-Boas; Renata Silva; Andreia Palmeira; Emília Sousa; Luísa Maria Ferreira; Paula Sério Branco; Félix Carvalho; Maria de Lourdes Bastos; Fernando Remião
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

3.  Chiral Thioxanthones as Modulators of P-glycoprotein: Synthesis and Enantioselectivity Studies.

Authors:  Ana Lopes; Eva Martins; Renata Silva; Madalena M M Pinto; Fernando Remião; Emília Sousa; Carla Fernandes
Journal:  Molecules       Date:  2018-03-10       Impact factor: 4.411

Review 4.  Cellular Models and In Vitro Assays for the Screening of modulators of P-gp, MRP1 and BCRP.

Authors:  Mariline Gameiro; Renata Silva; Carolina Rocha-Pereira; Helena Carmo; Félix Carvalho; Maria de Lourdes Bastos; Fernando Remião
Journal:  Molecules       Date:  2017-04-08       Impact factor: 4.411

5.  Histological and toxicological evaluation, in rat, of a P-glycoprotein inducer and activator: 1-(propan-2-ylamino)-4-propoxy-9H-thioxanthen-9-one (TX5).

Authors:  Carolina Rocha-Pereira; Vera Silva; Vera Marisa Costa; Renata Silva; Juliana Garcia; Salomé Gonçalves-Monteiro; Margarida Duarte-Araújo; Alice Santos-Silva; Susana Coimbra; Ricardo Jorge Dinis-Oliveira; Catarina Lopes; Paula Silva; Solida Long; Emília Sousa; Maria de Lourdes Bastos; Fernando Remião
Journal:  EXCLI J       Date:  2019-08-27       Impact factor: 4.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.